Search Results for

S2104 (JIT)

Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide Versus Observation in High-Risk Pancreatic Neuroendocrine Tumors

Continue Reading »

---

A021804

A Prospective, Multi-Institutional Phase II Trial Evaluating Temozolomide vs. Temozolomide and Olaparib for Advanced Pheochromocytoma and Paraganglioma

Continue Reading »

---

Search Again

• All Trial Categories Amyloidosis  (1) Anal  (1) Bladder/Urinary Tract Cancer  (7)    Adjuvant  (1)    Metastatic  (3)    Neoadjuvant  (1) Brain  (7)    Glioblastoma Multiforme (GBM)  (1)    Other Brain Tumors  (3) Breast  (14)    Breast Cancer Adjuvant  (1)    Breast Cancer Neoadjuvant  (2) Cancer Control/Symptom Management  (21) Carcinoid Tumors  (2) Colorectal Cancer  (7)    Metastatic  (1)    Rectal Neoadjuvant  (1) Esophageal Cancer  (3) Gastric Cancer  (3) Head/Neck Cancer  (8) Leukemia  (1) Lung Cancer  (18)    Non-Small Cell Lung Cancer  (14)       1st Line Metastatic, Stage3b with Maligned Effusion or Stage 4 Disease at Presentation or Recurrence  (2)       Adjuvant Treatment for Resected NSCLC  (2)    Small Cell Lung Cancer  (3)       Extensive Stage SCLC  (1) MATCH Trial  (3) Melanoma  (2) Merkel Cell Carcinoma  (1) Misc. Gynecology  (3) Multiple Myeloma  (2) Ovarian  (2) Pancreatic  (7)    Metastatic Disease  (1) Prostate  (8) Renal Cell/Kidney Cancer  (3)    Locally Advanced/Metastatic  (1) Sarcoma  (1)